Leiomyomas, benign smooth muscle tumors of the uterus, are the most common
gynecologic neoplasm in women. Studies with surgically resected human tissu
es and primary cultures have revealed that several genes are differentially
expressed in leiomyomas compared to matched normal myometrium. An estrogen
-driven pattern of gene expression in leiomyomas, similar to that seen in n
ormal myometrium during pregnancy and parturition, is associated with a per
sistent inappropriate response of neoplastic myometrial smooth muscle cells
to ovarian hormones. This is possibly due to aberrant expression levels or
signaling via estrogen and progesterone receptors. We propose the hypothes
is that uterine leiomyomas mimic a differentiated myometrial cell at pregna
ncy and exhibit a hypersensitivity to sex steroid hormones that prevents th
e cells from responding to normal apoptotic or dedifferentiation signals an
d from returning to a nongravid phenotype. Support of this hypothesis is de
rived from experimental studies in female Eker rats that develop uterine le
iomyomas with many similarities to the human disease. Our hypothesis accoun
ts for the benign nature of these tumors and their high incidence in women
during the reproductive years. By identifying the factors that participate
in parturition and involution of the pregnant myometrium, we may better def
ine uterine leiomyomas and thus identify novel targets for therapeutic stra
tegies to treat these tumors.